Abstract
We previously reported a high incidence of loss of heterozygosity (LOH) on chromosome 2q33 in neuroblastoma (NB), observed in various types of human cancers including lung cancer, head and neck cancer and follicular thyroid carcinoma. To better elucidate the role of chromosome 2q aberrations in NB, we examined common allelic imbalance (AI) regions on chromosome 2q in 82 NB patients using 10 polymorphic microsatellite markers. AI on 2q was detected in 26 (32%) of 82 NB cases. There was a distinct common AI region between the D2S115 and D2S307 markers on 2q33. The distance between these markers was about 2.0 cM. Recently, the caspase 8 and caspase 10 genes, both of which encode cystein protease, were mapped to chromosome 2q33. Since the common AI region on 2q33 includes the caspase 8 and caspase 10 genes, the alterations of these genes were examined further. Absent or reduced expression of caspase 8 and caspase 10 were found in 19 (70%) of 27 and two (7%) of 27 NB cell lines by reverse transcription-polymerase chain reaction, respectively. A missense mutation was detected at codon 96, GCT (Alanine) to GTT (Valine), of the caspase 8 gene in one of the NB cell lines lacking caspase 8 expression. Thirteen (68%) of 19 cell lines lacking caspase 8 expression displayed methylation of the CpG island of the caspase 8 gene, whereas only one (13%) of eight cell lines with caspase 8 expression showed caspase 8 methylation (P=0.031). Furthermore, there was a significant association between AI at 2q33 and loss of caspase 8 expression (P=0.026). These results indicated that there was a tumor suppressor gene in the common AI region on chromosome 2q33 involved in the pathogenesis of a subset of NB. It is possible that the caspase 8 gene is one of the candidate tumor suppressor genes for NB and inactivation of this gene plays an important role in the tumorigenesis of NB through mainly its methylation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Boldin MP, Goncharov TM, Goltsev YV, Wallach D . 1996 Cell 85: 803–815
Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM . 1984 Science (Washington DC) 224: 1121–1124
Ceyns V, Yuan J . 1998 Genes Dev. 12: 1551–1570
Evans AE, D'Angio GJ, Randolph J . 1971 Cancer (Phila.) 27: 374–378
Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES . 1996 Proc. Natl. Acad. Sci. USA 93: 7464–7469
Fong CT, Dracopoli NC, White PS, Merrill PT, Griffith RC, Housman DE, Brodeur GM . 1989 Proc. Natl. Acad. Sci. USA 86: 3753–3757
Fong CT, White PS, Peterson K, Sapienza C, Cavenee WK, Kern SE, Vogelstein B, Cantor AB, Look AT, Brodeur GM . 1992 Cancer Res. 52: 1780–1785
Fulda S, Lutz W, Schwab M, Debatin KM . 1999 Oncogene 18: 1479–1486
Grenet J, Teitz T, Wei T, Valentine V, Kidd VJ . 1999 Gene 226: 225–232
Herman JG, Jen J, Merlo A, Baylin SB . 1996 Cancer Res. 56: 722–727
Inoue A, Yokomori K, Tanabe H, Mizusawa H, Sofuni T, Hayashi Y, Tsuchida Y, Shimatake H . 1997 Int. J. Cancer 72: 1070–1077
Kaneko M, Nishihira H, Mugishima H, Ohnuma N, Nakada K, Kawa K, Fukuzawa M, Suita S, Sera Y, Tsuchida Y . 1998 Med. Pediatr. Onco. 31: 1–7
Kawano S, Miler CW, Gombart AF, Bartram CR, Matsuo Y, Asou H, Sakashita A, Said J, Tatsumi E, Koeffler HP . 1999 Blood 94: 1113–1120
Kohno T, Morishita K, Takano H, Shapiro DN, Yokota J . 1994 Oncogene 9: 103–108
Kong X-T, Choi SH, Inoue A, Xu F, Chen T, Takita J, Yokota J, Bessho F, Yanagisawa M, Hanada R, Yamamoto K, Hayashi Y . 1997a Cancer Res. 57: 3772–3778
Kong X-T, Choi SH, Inoue A, Takita J, Yokota J, Hanada R, Yamamoto K, Bessho F, Yanagisawa M, Hayashi Y . 1997b Eur. J. Cancer 33: 1962–1965
Kukita Y, Tahira T, Sommer SS, Hayashi K . 1997 Hum. Mutat. 10: 400–407
Lutz W, Fulda S, Jeremias I, Debatin KM, Schwab M . 1998 Oncogene 17: 339–346
Mandruzzato S, Brasseur F, Andry G, Boon T, van der Bruggen PA . 1997 J. Exp. Med. 186: 785–793
Maris JM, Matthy KK . 1999 J. Clin. Oncol. 17: 2264–2279
Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Bayline SB, Sidransky D . 1995 Nat. Med. 7: 686–692
Mullokandov MR, Kholodilov NG, Atkin NB, Burk RD, Johnson AB, Klinger HP . 1996 Cancer Res. 56: 197–205
Nishizuka S, Tamura G, Terashima M, Satodate R . 1998 J. Pathol. 185: 38–43
Otsuka T, Kohno T, Mori M, Noguchi M, Hirohashi S, Yokota J . 1996 Genes Chromosomes Cancer 16: 113–119
Ransom DT, Barnett TC, Bot J, de Boer B, Metcalf C, Davidson JA, Turbett GR . 1998 Head Neck 20: 404–410
Salvesen GS, Dixit VM . 1997 Cell 91: 443–446
Sawaguchi S, Kaneko M, Uchino J, Takeda T, Iwafuchi M, Matsuyama S, Takahashi H, Nakajo T, Hoshi Y, Okabe I, Yokoyama J, Nishihira H, Sakaki S, Sakurai M, Sawada T, Nagahara N, Tsuchida Y . 1990 Cancer (Phila.) 66: 1879–1887
Schwab M . 1993 Semin. Cancer Biol. 1: 13–18
Schwab M, Praml C, Amler LC . 1996 Genes Chromos. Cancer 16: 211–219
Schor NF . 1999 J. Neurooncol. 41: 159–166
Shiseki M, Kohno T, Nishikawa R, Sameshima Y, Mizoguchi H, Yokota J . 1994 Cancer Res. 54: 5643–5648
Stanbridge EJ . 1990 Annu. Rev. Genet. 24: 615–617
Takeda O, Homma C, Maseki N, Sakurai M, Kanda N, Schwab M, Nakamura Y, Kaneko Y . 1994 Genes Chromos. Cancer 10: 30–39
Takita J, Hayashi Y, Kohno T, Shiseki M, Yamaguchi N, Hanada R, Yamamoto K, Yokota J . 1995 Oncogene 11: 1829–1834
Takita J, Hayashi Y, Kohno T, Yamaguchi N, Hanada R, Yamamoto K, Yokota J . 1997 Cancer Res. 57: 907–912
Takita J, Hayashi Y, Nakajima T, Adachi J, Tanaka T, Yamaguchi N, Ogawa Y, Hanada R, Yamamoto K, Yokota J . 1998 Oncogene 17: 3137–3143
Takita J, Hayashi Y, Takei K, Yamaguchi N, Hanada R, Yamamoto K, Yokota J . 2000 Eur. J. Cancer 36: 508–513
Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM, Kidd VJ . 2000 Nat. Med. 6: 529–535
Tung WS, Shevlin DW, Kaleem Z, Tribune DJ, Wells Jr SA, Goodfellow PJ . 1997 Genes Chromos. Cancer 19: 43–51
Vincenz C, Dixit VM . 1997 J. Biol. Chem. 272: 6578–6583
Wang J, Zheng L, Lobito A, Chan FK, Dale J, Sneller M, Yao X, Puck JM, Straus SE, Lenardo MJ . 1999 Cell 98: 47–58
Yeh WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El-Deiry WS, Lowe SW, Goeddel DV, Mak TW, Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, Bredesen DE . 1998 Science (Washington DC) 279: 1954–1958
Yang HW, Piao HY, Chen YZ, Takita J, Kobayashi M, Taniwaki M, Hashizume K, Hanada R, Yamamoto K, Taki T, Bessho F, Yanagisawa M, Hayashi Y . 2000 Int. J. Mol. Med. 5: 379–384
Yokota J, Sugimura T . 1993 FASEB J. 7: 920–925
Zhang J, Cado D, Chen A, Kabra NH, Winoto A . 1998 Nature 392: 293–300
Acknowledgements
We would like to thank Mrs S Sohma and H Soga for their excellent technical assistance. We would also like to express our appreciation to Drs AT Look, Harvard Medical University, and A Inoue, Toho University School of Medicine, for their generous gift of NB cell lines. This work was supported in part by a Grant-in-Aid from the Ministry of Health and Welfare for Research on Human Genome and Gene Therapy and Grants-in-Aid from the Ministry of Health and Welfare and from the Ministry of Education, Science and Culture of Japan. This work was also supported by NCI grant (NIH 2RD1 CA67938) to UK and by NIH grant 21765 to the Cancer Center of SJCRH and the generous support of the American Lebanese Syrian Associate Charities (ALSAC).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takita, J., Yang, H., Chen, Y. et al. Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma. Oncogene 20, 4424–4432 (2001). https://doi.org/10.1038/sj.onc.1204521
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204521
Keywords
This article is cited by
-
Amplification and deletion of the RAPH1 gene in breast cancer patients
Molecular Biology Reports (2013)
-
Aberrant activation of ALK kinase by a novel truncated form ALK protein in neuroblastoma
Oncogene (2012)
-
Methylation of TMEFF2 Gene in Tissue and Serum DNA from Patients with Non-Small Cell Lung Cancer
Molecules and Cells (2012)
-
Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis
British Journal of Cancer (2011)
-
Oncogenic mutations of ALK kinase in neuroblastoma
Nature (2008)